TRIUMPH-1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
May 2026 — Vol. 3, No. 5
Page 2 of 4 of this archive, newest first.
Also filed — page 2
the rolling newsroom, May 2026Portugal health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
PeptideMeter result on a Wuxi dulaglutide lot lands 2.2 points above the supplier’s stated figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What changed at QST in May, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Nigeria caps exenatide prescribing to 23 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The relabeller trading as Vantris Bio closes after 24 years
A proper account of an operation that existed, and of what closing it cost.
STEP 1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The United Arab Emirates declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A shortage listing ends. 9 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
PeptideMeter result on a Changsha mazdutide lot lands 4.4 points above the supplier’s stated figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What changed at QST in May, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A supplier suspends shipping to the United Kingdom after 14 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Xianning export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
The 28-day notice: how a compounding wind-down works in South Korea
The document is four pages. Three of them are about dates.
Inspectors cite Calder Vale Peptides of Skipton over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What the new Switzerland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
A supplier suspends shipping to Argentina after 22 consecutive customs detentions
The route did not close because of a rule about peptides.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Independent analysis puts a Homopeptide retatrutide lot at 98.3%, against 97.3% on the certificate
The result is unremarkable. What the report states alongside it is not.
Japan pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
SURMOUNT-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
South Korea declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The online reseller trading as Adamant Research Supply closes after 11 years
A proper account of an operation that existed, and of what closing it cost.
What changed at WXT in May, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Spain caps semaglutide prescribing to 3 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of Halvard & Pike Apothecary of Portland, Maine
A proper account of an operation that existed, and of what closing it cost.
Australia declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
SURMOUNT-OSA misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.